Patients with NAFLD and NASH exhibit elevated leptin levels and decreased adiponectin levels, which are associated with the severity of NAFLD patients, probably reflecting the increasing insulin resistance [8,52]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatohepatitis.